This article and associated images are based on a poster originally authored by Marina Fedorova and Ian Hiles and presented at ELRIG Drug Discovery 2024 in affiliation with GSK. This poster is being ...
Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.
Proteins are made of chains of amino acids, and a basic tenet of biology is that the sequence of amino acids determines how a protein folds into a 3D shape which, in turn, dictates the protein’s ...
Nuclera and leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins
CAMBRIDGE, England & BOSTON & VILLIGEN, Switzerland--(BUSINESS WIRE)--Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based ...
“Imagine a future in which you can design enzymes - natures catalysts – for your specific application at the push of button”, says Gustav Oberdorfer who headed the ERC Starting Grant project ...
What if we could design proteins that mimic nature’s signaling mechanisms but with enhanced precision and stability? A recent study published in Nature Chemistry ventured into the groundbreaking realm ...
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Nuclera, the biotechnology company enabling rapid access to high-quality proteins and leadXpro, a specialist in structure-based drug discovery for membrane proteins, today announced a scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results